Panama vs United States of America: Proportion of isolates with resistance to ciprofloxacin reported to
Panama
33.3
in 2018
United States of America
31.22
in 2018
Panama rank
48th
United States of America rank
50th
Proportion of isolates with resistance to ciprofloxacin reported to over time
- Panama
- United States of America
How they compare
Panama currently reports 33.3 against 31.22 in United States of America, a difference of 2.08.
That makes Panama's figure about 1.1 times United States of America's.
The two have swapped places 3 times across 5 shared years of data; in 2010 it was United States of America ahead.
Panama ranks 48th and United States of America ranks 50th of 54 countries.
Panama has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with resistance to ciprofloxacin reported to, Panama or United States of America?
- Panama, at 33.3 against 31.22 in United States of America as of 2018.
- What is the difference in proportion of isolates with resistance to ciprofloxacin reported to between Panama and United States of America?
- 2.08, with Panama ahead.
- How many years of comparable data are there for Panama and United States of America?
- 5 years are reported by both, from 2010 to 2018.
- How do Panama and United States of America rank globally for proportion of isolates with resistance to ciprofloxacin reported to?
- Panama ranks 48th and United States of America ranks 50th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.